IMNN (STOCKS)
Imunon, Inc. Common Stock
$2.886900
-0.103100 (-3.45%)
Prev close: $2.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stacy R. Lindborg
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.61M
- Employees
- 25
- P/E (TTM)
- -0.37
- P/B (TTM)
- 1.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.99 | $-1.20 | -0.7925 | -66.18% |
|
Sep 2025 (Q3)
|
$-1.16 | $-1.84 | +0.6813 | +37.00% |
|
Jun 2025 (Q2)
|
$-1.87 | $-4.20 | +2.3346 | +55.53% |
|
Mar 2025 (Q1)
|
$-3.65 | $-4.66 | +1.0043 | +21.57% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $155.67K |
| Operating Expenses | $14.65M |
| Research and Development | $7.78M |
| Other Operating Expenses | $6.87M |
| Operating Income/Loss | -$14.65M |
| Income/Loss From Continuing Operations After Tax | $14.50M |
| Income/Loss From Continuing Operations Before Tax | $14.50M |
| Net Income/Loss | -$14.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$14.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.83 |
| Diluted Earnings Per Share | -$6.83 |
| Basic Average Shares | 2,123,344 |
| Diluted Average Shares | 2,123,344 |
| Assets | $12.29M |
| Current Assets | $10.72M |
| Cash | $8.80M |
| Other Current Assets | $1.92M |
| Noncurrent Assets | $1.56M |
| Fixed Assets | $529.94K |
| Other Non-current Assets | $1.03M |
| Liabilities | $5.23M |
| Current Liabilities | $4.62M |
| Wages | $1.61M |
| Other Current Liabilities | $3.01M |
| Noncurrent Liabilities | $602.41K |
| Equity | $7.06M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.06M |
| Liabilities And Equity | $12.29M |
| Net Cash Flow From Operating Activities | -$13.90M |
| Net Cash Flow From Operating Activities, Continuing | -$13.90M |
| Net Cash Flow From Investing Activities | -$280.57K |
| Net Cash Flow From Investing Activities, Continuing | -$280.57K |
| Net Cash Flow From Financing Activities | $17.09M |
| Net Cash Flow From Financing Activities, Continuing | $17.09M |
| Net Cash Flow | $2.91M |
| Net Cash Flow, Continuing | $2.91M |
| Comprehensive Income/Loss | -$14.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$14.50M |
| Other Comprehensive Income/Loss | $0.00 |